Flatley Jay T. - 06 Aug 2021 Form 4 Insider Report for Zymergen Inc.

Reporting relationship: Chairman and Acting CEO, Director
Issuer ticker: N/A
Reported as of: 06 Aug 2021
Net transaction value: $0
SEC form: 4
Accepted by SEC: 09 Aug 2021, 20:50:55 UTC
Prior SEC filing: 04 Jun 2021
Next SEC filing: 09 Nov 2021
Source filing: View source filing
Reporting owner signature: /s/ Mina Kim, attorney-in-fact

Key filing fact

Flatley Jay T. filed Form 4 for Zymergen Inc. on 09 Aug 2021.

Key facts

This page summarizes Flatley Jay T.'s Form 4 filing for Zymergen Inc..
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 09 Aug 2021, 20:50.

Change

Previous filing in this sequence was filed on 04 Jun 2021.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ZY transaction Derivative

Stock Options

Award

Transaction value: $0
Shares: +1,520,000
Change %
Price: $0.000000
Shares after: 1,520,000
Date: 06 Aug 2021
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 1,520,000
Exercise price: $12.33
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The Options vest in eight substantially equal installments on each quarterly anniversary of August 2, 2021 (the date of Reporting Person's appointment as Acting Chief Executive Officer), subject to Reporting Person's continued service as Acting Chief Executive Officer, Chairman of the Board of Directors or Lead Independent Director of the Board of Directors through such date.